Nircef capsules

Dexa Medica

Ingredients in every capsule

Cefdinir 100 mg

Each package contains

1 strip of 10 capsules

Other details

Dosage form:Capsule; hard
Flavour None

W.H.O. classification

ATC Level 1 J - Antiinfectives for systemic use
ATC Level 2 J01 - Antibacterials for Systemic Use
ATC Level 3 J01D - Other Beta-Lactam Antibacterials in ATC

Warnings

Pregnancy

CONSULT YOUR DOCTORSafety of this item for use during pregnancy has not been established. Please consult your doctor.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Available in

Indonesia

Dosage information

12 YEARS OLD AND ABOVE
— Respiratory tract infections and other infections caused by susceptible Gram-positive bacteria:
3 x 100 mg/day (3 x 1 capsule/day)

— Severe infections caused by susceptible Gram-negative bacteria:
2 x 300 mg/day (3 capsules in the morning and 3 capsules in the evening)

— Uncomplicated urinary tract infections:
2 x 100 mg/day (1 capsule in the morning and 1 capsule in the evening)

UP TO 12 YEARS
Safety has not been established

ADMINISTRATION
To minimize the appearance of organisms resistant to cefdinir, as a rule the susceptibility of causative organisms should be confirmed before use and administration should be limited to the shortest period that is needed for the treatment of the infection.

Indication

Cefdinir is indicated for the treatment of the following infections caused by susceptible strains of the designated microorganisms in the following diseases:
– Upper respiratory tract infections caused by Streptococcus pyogenes.
– Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.
– Lower respiratory tract infections caused by Streptococcus pneumoniae and Haemophilus influenzae (β-lactamases positive and negative strains).
– Urinary tract infections caused by Escherichia coli and Proteus mirabilis.